Self-reported conflicts of interest (sfCOI) of authors and the interpretation of randomized phase III trials (RCT) and related editorials (REd) in cancer research.
Giovanni Mendonca Bariani
Other Remuneration - Roche
Anezka Carvalho Rubin De Celis Ferrari
Other Remuneration - Roche
Paulo Marcelo Hoff
No relevant relationships to disclose
Rachel Riechelmann
Consultant or Advisory Role - Merck Serono; Novartis
Honoraria - Bayer; Merck Serono; Novartis; Roche
Other Remuneration - Bayer; Merck Serono; Novartis; Roche